Presented by: Jacqueline A. French, M.D., President, and Joyce A. Cramer,President, Epilepsy Therapy
Overview: The Epilepsy Study Consortium (ESC) partners with Epilepsy Therapy Project (ETP) to support development of new therapies for epilepsy. They nurture entrepreneurs through preclinical stages and facilitation of early clinical testing. Scientific/regulatory/business experience circumvents roadblocks in dealing with academic centers. Collaboration with industry and regulatory agencies optimizes clinical trial methodology with novel proof-of-principle trial designs to identify compounds that will have a competitive advantage in efficacy, safety, ease of use, or spectrum of activity. They spearhead improved phase II-III trial designs to speed clinical evaluation. The collaboration enhances the environment for exploration in epilepsy treatments.
